ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.76B
Enterprise Value 31.48B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.49
Price/Book (mrq)6.63
Enterprise Value/Revenue 37.99
Enterprise Value/EBITDA 6-5.87

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin -135.99%
Operating Margin (ttm)-137.54%

Management Effectiveness

Return on Assets (ttm)-41.26%
Return on Equity (ttm)-74.04%

Income Statement

Revenue (ttm)185.07M
Revenue Per Share (ttm)1.49
Quarterly Revenue Growth (yoy)87.20%
Gross Profit (ttm)111.84M
EBITDA -251.68M
Net Income Avi to Common (ttm)-251.68M
Diluted EPS (ttm)-2.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)256.86M
Total Cash Per Share (mrq)2.06
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.12
Book Value Per Share (mrq)2.12

Cash Flow Statement

Operating Cash Flow (ttm)-174.51M
Levered Free Cash Flow (ttm)-83.65M

Trading Information

Stock Price History

Beta 4.01
52-Week Change 3-62.01%
S&P500 52-Week Change 315.37%
52 Week High 341.20
52 Week Low 312.77
50-Day Moving Average 314.23
200-Day Moving Average 317.73

Share Statistics

Avg Vol (3 month) 32.79M
Avg Vol (10 day) 31.4M
Shares Outstanding 5125.01M
Float 97.68M
% Held by Insiders 10.12%
% Held by Institutions 195.93%
Shares Short (Aug 31, 2018) 415.85M
Short Ratio (Aug 31, 2018) 46.43
Short % of Float (Aug 31, 2018) 420.12%
Short % of Shares Outstanding (Aug 31, 2018) 412.68%
Shares Short (prior month Jul 31, 2018) 416.53M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A